BW
BIO icon

Bravera Wealth’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bravera Wealth’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14
Closed -$3.9K – 357
2026
Q1 		$3.9K Hold
14
– – ﹤0.01% 357
2025
Q4 		$4.24K Buy
+14
New +$4.37K ﹤0.01% 381

Other funds holding BIO

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
SGH
Sivik Global Healthcare Greenwich, Connecticut $132M AUM 24.1% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Bravera Wealth's BIO Position: Q2 2026 in Review

Bravera Wealth sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2026, closing a stake of 14 shares — an estimated $3.9K sold.

Bravera Wealth first reported a position in BIO in Q4 2025 and held it in 2 quarters. The position peaked at $4.24K in Q4 2025. 72 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Bravera Wealth reported no remaining Bio-Rad Laboratories Class A position as of Q2 2026 after selling out during the quarter.
  • Bravera Wealth sold 14 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $3.9K.
  • Bravera Wealth first reported a position in Bio-Rad Laboratories Class A in Q4 2025 and held it in 2 quarters.
  • Bravera Wealth's Bio-Rad Laboratories Class A position peaked at $4.24K in Q4 2025.
  • 72 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Bravera Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.